Intrathecal Morphine is one of 242 small molecule programs targeting Metastasis. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
230 competitors in Cesarean Section
Intrathecal Morphine
Marcaine
Naropin
Xylocaine
Ancef
Nubain
Glucophage
Imdur
Bactroban
Sufenta
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details